Assessing mental health and quality of life in lupus patients
Official title: Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
Run by Assiut University · NCT05971498 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how lupus affects mental health and quality of life by comparing anxiety, depression, and sleep quality in lupus patients to healthy people.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT05971498 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Systemic Lupus Erythematosus according to the SLICC criteria.
✕Probably not a fit
Patients with evidence of end-organ failures or a history of psychological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate anxiety, depression, sleep quality, and overall quality of life in patients diagnosed with Systemic Lupus Erythematosus (SLE). It will compare these factors between SLE patients and healthy subjects, while also examining the relationship between psychological well-being and disease activity. Clinical evaluations will include comprehensive laboratory tests and psychological assessments using standardized scales. The study seeks to provide insights into how SLE affects mental health and quality of life.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the psychological impacts of SLE, leading to improved patient care and support.
How similar studies have gone: While studies assessing mental health in chronic illnesses exist, this specific focus on SLE and its psychological dimensions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with SLE according to the 2012 systemic lupus international collaborating clinics (SLICC) criteria . Exclusion Criteria: * Evidence of end-organ failures such as heart failure, liver cell or renal failure, * History of psychological disorders .
Where it's running
-
Faculty of medicine, Assiut university hospital
Assiut, Egypt Recruiting
Study contacts
- Study coordinator: Maha Abdelrahman, MD,PhD
- Email: mahasayed@aun.edu.eg
- Phone: +201011212050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of anifrolumab on arterial inflammation in SLE patients
This study tests whether anifrolumab can reduce blood vessel inflammation in people with active systemic lupus erythematosus.
-
Home urine testing for people with lupus
Participants with lupus will try weekly home urine tests in addition to usual care to see if this helps monitor kidney health over a year.
-
CR-402 treatment for refractory autoimmune disease
This study tests CRT-402, a CD19-targeted CAR-T therapy, in adults with active, treatment-resistant autoimmune diseases like SLE, systemic sclerosis, and inflammatory myopathy to see if it is safe and capable of helping control disease.
-
ATG-201 in adults with autoimmune diseases
This early, open-label study tests ATG-201 in adults with autoimmune diseases to see if it is safe and tolerable, and to get initial clues about how the body handles the drug and its effects.
-
Biomarker tests in adults with lupus to see how kidney disease changes over time
Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.
-
Sirolimus added to standard therapy for adults with SLE-associated immune thrombocytopenia
This trial tests whether adding sirolimus to usual treatment helps adults with SLE-related immune thrombocytopenia see their platelet counts improve.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.